Please enable JavaScript to continue using this application.

Compare $ACHV vs $SLDB | Chartloom

Compare

$ACHV vs $SLDB

Achieve Life Sciences Inc · Solid Biosciences Inc

ACHV

Achieve Life Sciences Inc

SLDB

Solid Biosciences Inc

Compare $ACHV vs $SLDB

Comparing Achieve Life Sciences Inc and Solid Biosciences Inc

ACHVAchieve Life Sciences Inc

SLDBSolid Biosciences Inc

ACHVAchieve Life Sciences Inc

Market cap

$761M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-89.3%

YTD performance

49.1%

52W performance

114.8%

FCF yield

-6.2%

SLDBSolid Biosciences Inc

Market cap

$676M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

26.1%

52W performance

8.9%

FCF yield

-27.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACHV

SLDB

Detailed metrics comparison

ACHV

Achieve Life Sciences Inc

SLDB

Solid Biosciences Inc

Market Cap

ACHV$761M

SLDB$676M

Enterprise Value

ACHV$728M

SLDB$517M

Price

ACHV$7.41

SLDB$6.87

P/E Ratio

ACHVN/A

SLDBN/A

P/S Ratio

ACHV41.81x

SLDB49.66x

EV/Sales

ACHV39.95x

SLDB38.88x

EV/EBITDA

ACHV0.00x

SLDB0.00x

P/B Ratio

ACHV69.77x

SLDB1.96x

P/FCF Ratio

ACHVN/A

SLDBN/A

EV/FCF

ACHV-15.41x

SLDB-2.75x

PEG Ratio

ACHVN/A

SLDBN/A

Forward P/E (NTM)

ACHVN/A

SLDBN/A

Forward P/S (NTM)

ACHVN/A

SLDBN/A

Revenue (TTM)

ACHV$0

SLDB$0

Revenue Growth (YoY)

ACHV-89.3%

SLDBN/A

Forward Rev Growth

ACHV281.2%

SLDB822.7%

Gross Margin (TTM)

ACHV0.0%

SLDB0.0%

Operating Margin (TTM)

ACHV0.0%

SLDB0.0%

EBITDA Margin (TTM)

ACHV0.0%

SLDB0.0%

Net Margin (TTM)

ACHV0.0%

SLDB0.0%

FCF Margin (TTM)

ACHVN/A

SLDBN/A

Net Income (TTM)

ACHV$-114M

SLDB$-207M

FCF (TTM)

ACHV$-47M

SLDB$-188M

EPS (TTM)

ACHV-$1.22

SLDB-$1.44

ROE (TTM)

ACHV-19349.0%

SLDB-7228.0%

ROA (TTM)

ACHV-14373.0%

SLDB-6137.0%

ROIC (TTM)

ACHV-13245.0%

SLDB-7226.0%

Cash

ACHV$48M

SLDB$159M

Debt

ACHV$15M

SLDB$0

Net Cash/Debt

ACHV$33M

SLDB$159M

Current Ratio (TTM)

ACHV0.95x

SLDB13.82x

Quick Ratio (TTM)

ACHV0.95x

SLDB13.24x

Debt/Equity (TTM)

ACHV1.40x

SLDB0.00x

Debt/Assets (TTM)

ACHV0.0%

SLDB0.0%

Interest Coverage (TTM)

ACHVN/A

SLDBN/A

Net Debt/EBITDA (TTM)

ACHV0.00x

SLDB0.00x

Beta

ACHV2.44

SLDB2.60

52W Performance

ACHV114.8%

SLDB8.9%

YTD Performance

ACHV49.1%

SLDB26.1%

% from 52W High

ACHV-14.2%

SLDB-40.0%

% from 52W Low

ACHV182.8%

SLDB81.3%

Asset Turnover (TTM)

ACHV0.33x

SLDB0.07x

FCF Yield (TTM)

ACHV-6.2%

SLDB-27.8%

Earnings Yield (TTM)

ACHV-15.0%

SLDB-30.6%

Dividend Yield (TTM)

ACHVN/A

SLDBN/A

Rule of 40

ACHV-89.3

SLDB0.0

EV/GP/RG

ACHVN/A

SLDBN/A

Ticker research

View ACHV research View SLDB research

Metric	ACHV Achieve Life Sciences Inc	SLDB Solid Biosciences Inc
Market & Valuation
Market Cap	$761M	$676M
Enterprise Value	$728M	$517M
Price	$7.41	$6.87
P/E Ratio	N/A	N/A
P/S Ratio	41.81x	49.66x
EV/Sales	39.95x	38.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	69.77x	1.96x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.41x	-2.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-89.3%	N/A
Forward Rev Growth	281.2%	822.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-114M	$-207M
FCF (TTM)	$-47M	$-188M
EPS (TTM)	-$1.22	-$1.44
ROE (TTM)	-19349.0%	-7228.0%
ROA (TTM)	-14373.0%	-6137.0%
ROIC (TTM)	-13245.0%	-7226.0%
Financial Health
Cash	$48M	$159M
Debt	$15M	$0
Net Cash/Debt	$33M	$159M
Current Ratio (TTM)	0.95x	13.82x
Quick Ratio (TTM)	0.95x	13.24x
Debt/Equity (TTM)	1.40x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.44	2.60
52W Performance	114.8%	8.9%
YTD Performance	49.1%	26.1%
% from 52W High	-14.2%	-40.0%
% from 52W Low	182.8%	81.3%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.07x
FCF Yield (TTM)	-6.2%	-27.8%
Earnings Yield (TTM)	-15.0%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-89.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACHV research	View SLDB research

Valuation

P/S Ratio

ACHV

41.81x

SLDB

49.66x

EV/FCF

ACHV

-15.41x

SLDB

-2.75x

Growth & revenue

Revenue Growth TTM

ACHV

-89.3%

Forward Revenue Growth

SLDB

822.7%

ACHV

281.2%

Profitability & performance

Gross Margin

ACHV

0.0%

SLDB

0.0%

ROE

SLDB

-7228.0%

ACHV

-19349.0%

FCF Yield %

ACHV

-6.2%

SLDB

-27.8%

52-Week Performance

ACHV

114.8%

SLDB

8.9%

Detailed metrics comparison

ACHV

Achieve Life Sciences Inc

SLDB

Solid Biosciences Inc

Market Cap

ACHV$761M

SLDB$676M

Enterprise Value

ACHV$728M

SLDB$517M

Price

ACHV$7.41

SLDB$6.87

P/E Ratio

ACHVN/A

SLDBN/A

P/S Ratio

ACHV41.81x

SLDB49.66x

EV/Sales

ACHV39.95x

SLDB38.88x

EV/EBITDA

ACHV0.00x

SLDB0.00x

P/B Ratio

ACHV69.77x

SLDB1.96x

P/FCF Ratio

ACHVN/A

SLDBN/A

EV/FCF

ACHV-15.41x

SLDB-2.75x

PEG Ratio

ACHVN/A

SLDBN/A

Forward P/E (NTM)

ACHVN/A

SLDBN/A

Forward P/S (NTM)

ACHVN/A

SLDBN/A

Revenue (TTM)

ACHV$0

SLDB$0

Revenue Growth (YoY)

ACHV-89.3%

SLDBN/A

Forward Rev Growth

ACHV281.2%

SLDB822.7%

Gross Margin (TTM)

ACHV0.0%

SLDB0.0%

Operating Margin (TTM)

ACHV0.0%

SLDB0.0%

EBITDA Margin (TTM)

ACHV0.0%

SLDB0.0%

Net Margin (TTM)

ACHV0.0%

SLDB0.0%

FCF Margin (TTM)

ACHVN/A

SLDBN/A

Net Income (TTM)

ACHV$-114M

SLDB$-207M

FCF (TTM)

ACHV$-47M

SLDB$-188M

EPS (TTM)

ACHV-$1.22

SLDB-$1.44

ROE (TTM)

ACHV-19349.0%

SLDB-7228.0%

ROA (TTM)

ACHV-14373.0%

SLDB-6137.0%

ROIC (TTM)

ACHV-13245.0%

SLDB-7226.0%

Cash

ACHV$48M

SLDB$159M

Debt

ACHV$15M

SLDB$0

Net Cash/Debt

ACHV$33M

SLDB$159M

Current Ratio (TTM)

ACHV0.95x

SLDB13.82x

Quick Ratio (TTM)

ACHV0.95x

SLDB13.24x

Debt/Equity (TTM)

ACHV1.40x

SLDB0.00x

Debt/Assets (TTM)

ACHV0.0%

SLDB0.0%

Interest Coverage (TTM)

ACHVN/A

SLDBN/A

Net Debt/EBITDA (TTM)

ACHV0.00x

SLDB0.00x

Beta

ACHV2.44

SLDB2.60

52W Performance

ACHV114.8%

SLDB8.9%

YTD Performance

ACHV49.1%

SLDB26.1%

% from 52W High

ACHV-14.2%

SLDB-40.0%

% from 52W Low

ACHV182.8%

SLDB81.3%

Asset Turnover (TTM)

ACHV0.33x

SLDB0.07x

FCF Yield (TTM)

ACHV-6.2%

SLDB-27.8%

Earnings Yield (TTM)

ACHV-15.0%

SLDB-30.6%

Dividend Yield (TTM)

ACHVN/A

SLDBN/A

Rule of 40

ACHV-89.3

SLDB0.0

EV/GP/RG

ACHVN/A

SLDBN/A

Ticker research

View ACHV research View SLDB research

Metric	ACHV Achieve Life Sciences Inc	SLDB Solid Biosciences Inc
Market & Valuation
Market Cap	$761M	$676M
Enterprise Value	$728M	$517M
Price	$7.41	$6.87
P/E Ratio	N/A	N/A
P/S Ratio	41.81x	49.66x
EV/Sales	39.95x	38.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	69.77x	1.96x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.41x	-2.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-89.3%	N/A
Forward Rev Growth	281.2%	822.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-114M	$-207M
FCF (TTM)	$-47M	$-188M
EPS (TTM)	-$1.22	-$1.44
ROE (TTM)	-19349.0%	-7228.0%
ROA (TTM)	-14373.0%	-6137.0%
ROIC (TTM)	-13245.0%	-7226.0%
Financial Health
Cash	$48M	$159M
Debt	$15M	$0
Net Cash/Debt	$33M	$159M
Current Ratio (TTM)	0.95x	13.82x
Quick Ratio (TTM)	0.95x	13.24x
Debt/Equity (TTM)	1.40x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.44	2.60
52W Performance	114.8%	8.9%
YTD Performance	49.1%	26.1%
% from 52W High	-14.2%	-40.0%
% from 52W Low	182.8%	81.3%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.07x
FCF Yield (TTM)	-6.2%	-27.8%
Earnings Yield (TTM)	-15.0%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-89.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACHV research	View SLDB research